Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

The role of central CYP2D6 metabolism in conveying neuroprotection in a harmine tremor model of Essential Tremor

FY 2015-16

Summary
The enzyme CYP2D metabolizes over 20% of drugs and neurotoxins. Variation in brain CYP2D is associated with altered risk for some neurodegenerative diseases. Among these is Essential Tremor (ET), the most common neurodegenerative disorder, in which patients experience tremor and cognitive deficits. Disease severity is linked to elevated levels of molecules called beta-carbolines. This includes harmine, a drug used to study ET, because it induces a similar tremor. CYP2D breaks down harmine and other similar molecules to harmless metabolites. Elevated CYP2D in the brain may inactivate these molecules more rapidly, while less CYP2D may allow accumulation in the brain, leading to tissue damage and tremor disorders like ET. In humans, CYP2D activity is highly genetically variable, which may account for genetic predisposition to ET, where people with a lot of CYP2D are protected and people with less CYP2D are more vulnerable to ET. Levels of brain CYP2D are also influenced by environmental factors; drugs like nicotine can increase brain CYP2D levels, potentially leading to neuroprotection, and drugs that inhibit CYP2D might increase susceptibility to the disease.Our objective is to investigate how genetic variation and environmental factors influence risk of ET. We model genetic variation using two strains of mice, one with more CYP2D activity and one with less, and we model environmental factors by giving an inhibitor to one group and an inducer CYP2D to another. We will give harmine and compare various measures of intoxication, including tremor severity and hypothermia, between groups. We hypothesize that greater brain CYP2D activity in both models will result in reduced tremor and hypothermia severity.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
350076
Name
Stocco Marlaina R
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The role of central CYP2D6 metabolism in conveying neuroprotection in a harmine tremor model of Essential Tremor
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Brain Metabolism; Cyp2d6; Genetic Variation; Harmine; Hypothermia; Induction; Inhibitor; Neurodegeneration; Transgenic Mouse; Tremor
Abstract
The enzyme CYP2D metabolizes over 20% of drugs and neurotoxins. Variation in brain CYP2D is associated with altered risk for some neurodegenerative diseases. Among these is Essential Tremor (ET), the most common neurodegenerative disorder, in which patients experience tremor and cognitive deficits. Disease severity is linked to elevated levels of molecules called beta-carbolines. This includes harmine, a drug used to study ET, because it induces a similar tremor. CYP2D breaks down harmine and other similar molecules to harmless metabolites. Elevated CYP2D in the brain may inactivate these molecules more rapidly, while less CYP2D may allow accumulation in the brain, leading to tissue damage and tremor disorders like ET. In humans, CYP2D activity is highly genetically variable, which may account for genetic predisposition to ET, where people with a lot of CYP2D are protected and people with less CYP2D are more vulnerable to ET. Levels of brain CYP2D are also influenced by environmental factors; drugs like nicotine can increase brain CYP2D levels, potentially leading to neuroprotection, and drugs that inhibit CYP2D might increase susceptibility to the disease.Our objective is to investigate how genetic variation and environmental factors influence risk of ET. We model genetic variation using two strains of mice, one with more CYP2D activity and one with less, and we model environmental factors by giving an inhibitor to one group and an inducer CYP2D to another. We will give harmine and compare various measures of intoxication, including tremor severity and hypothermia, between groups. We hypothesize that greater brain CYP2D activity in both models will result in reduced tremor and hypothermia severity.
Competitiondate
201512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Stocco, Marlaina R
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~